Drug: Cetuximab Injury: Disease progression Quarter: 2016Q3
Total Records: 19 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 125241632 | Cetuximab | Disease progression | RANBAXY | 60.00 YR | F | 0 | 20160707 | GB |
| 125297591 | Cetuximab | Disease progression | CIPLA | 0.00 | 0 | 20160706 | AT | |
| 125562881 | Cetuximab | Disease progression | CIPLA | 0.00 | 0 | 20160714 | DK | |
| 125563971 | Cetuximab | Disease progression | CIPLA | 0.00 | 0 | 20160714 | DK | |
| 125564011 | Cetuximab | Disease progression | CIPLA | 0.00 | 0 | 20160714 | DK | |
| 125564421 | Cetuximab | Disease progression | CIPLA | 0.00 | 0 | 20160714 | DK | |
| 125608042 | CETUXIMAB | Disease progression | PFIZER | 0.00 | M | 74 KG | 20160801 | US |
| 125819201 | Cetuximab | Disease progression | CIPLA | 0.00 | 0 | 20160722 | AU | |
| 125819231 | Cetuximab | Disease progression | CIPLA | 0.00 | 0 | 20160722 | AU | |
| 125819461 | Cetuximab | Disease progression | CIPLA | 0.00 | 0 | 20160722 | AU | |
| 125928631 | CETUXIMAB | Disease progression | ELI LILLY AND CO | 0.00 | M | 57 KG | 20160726 | DE |
| 125976682 | CETUXIMAB | Disease progression | SANDOZ | 61.00 YR | F | 0 | 20160803 | JP |
| 126066912 | Cetuximab | Disease progression | RANBAXY | 61.00 YR | F | 0 | 20160820 | JP |
| 126629001 | Cetuximab | Disease progression | CIPLA | 0.00 | 0 | 20160818 | IT | |
| 126629161 | Cetuximab | Disease progression | CIPLA | 0.00 | 0 | 20160818 | IT | |
| 126629191 | Cetuximab | Disease progression | CIPLA | 0.00 | 0 | 20160818 | IT | |
| 126629381 | Cetuximab | Disease progression | CIPLA | 0.00 | 0 | 20160818 | IT | |
| 127154831 | Cetuximab | Disease progression | CIPLA | 0.00 | 0 | 20160906 | BE | |
| 127751131 | CETUXIMAB | Disease progression | PFIZER | 73.00 YR | F | 0 | 20160923 | US |
Total Records: 19 Number of Pages: 1